These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 9759744)

  • 1. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
    Hawkey CJ; Tulassay Z; Szczepanski L; van Rensburg CJ; Filipowicz-Sosnowska A; Lanas A; Wason CM; Peacock RA; Gillon KR
    Lancet; 1998 Sep; 352(9133):1016-21. PubMed ID: 9759744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
    Lai KC; Lam SK; Chu KM; Hui WM; Kwok KF; Wong BC; Hu HC; Wong WM; Chan OO; Chan CK
    Aliment Pharmacol Ther; 2003 Oct; 18(8):829-36. PubMed ID: 14535877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
    Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ
    Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
    Lai KC; Lau CS; Ip WY; Wong BC; Hui WM; Hu WH; Wong RW; Lam SK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):799-805. PubMed ID: 12641502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Helicobacter pylori eradication useful in patients taking NSAIDs?
    Hawkey CJ
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S47-50; discussion S73. PubMed ID: 10503823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
    Gisbert JP; Hermida C; Pajares JM
    Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
    Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A
    Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
    Deltenre M; Jonas C; van Gossum M; Buset M; Otero J; De Koster E
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S39-44. PubMed ID: 8574734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
    Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.
    You JH; Lau W; Lee IY; Yung M; Ching JY; Chan FK; Lee KK
    Int J Clin Pharmacol Ther; 2006 Apr; 44(4):149-53. PubMed ID: 16625983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
    McColl KE; el-Nujumi A; Murray LS; el-Omar EM; Dickson A; Kelman AW; Hilditch TE
    Gut; 1998 May; 42(5):618-22. PubMed ID: 9659153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.